Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Universal helmet laws reduce traumatic brain injuries in young motorcyclists, according to trauma surgeons

  • Potential treatment target for cocaine addiction identified by study

  • New discovery could lead to more targeted head and neck cancer therapies

  • New molecule sneaks medicines across blood-brain barrier

  • One hormone, Two roles: Sugars differentiate seasonality, metabolism

  • For stroke patients, hospital bed position is delicate balancing act

  • Novel tinnitus therapy helps patients cope with phantom noise

  • People change their moral values to benefit themselves over others

  • Digital Therapist: Computer program analyzes speech, mental health

  • High prevalence of vitamin D deficiency across the board in neuromuscular disease

  •